BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

PolyU Researchers Discover Key Mechanism in Eye Pressure Regulation for Glaucoma Treatment

Glaucoma is one of the leading causes of visual impairment and blindness. According to statistics from the Hospital Authority, in Hong Kong, three out of e...

July 26, 2024 | News

Sirnaomics Completes IND-Enabling Studies for siRNA Therapeutic STP125G Targeting ApoC3

Sirnaomics Ltd. (the “Company”, Stock Code: 2257.HK, together with its subsidiaries, the “Group” or “Sirnaomics”),...

July 24, 2024 | News

Pfizer Announces Launch of Bivalent RSV Vaccine in Hong Kong and Macau

Pfizer Inc. has announced the availability of its bivalent RSV prefusion F (RSVpreF) vaccine in Hong Kong this month. Approved by health authorities in Hon...

July 19, 2024 | News

CUHK Faculty of Medicine Identifies Gut Microbial Markers for Autism Diagnosis

The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) has conducted a large cohort study among 1,627 children with and w...

July 12, 2024 | News

Eisai and Biogen Announce Approval of LEQEMBI® (Lecanemab) for Alzheimer’s Disease Treatment in Hong Kong

LEQEMBI is now available for patients with mild cognitive impairment (MCI) or mild dementia, collectively referred to as early AD, the population in which ...

July 11, 2024 | News

Sirnaomics Completes Phase I Clinical Study of STP707 for Pancreatic Cancer with Strong Safety Profile and Promising Disease Stability

Sirnaomics , a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announced that the Group h...

July 01, 2024 | News

Asia Summit on Global Health and Hong Kong International Medical and Healthcare Fair Conclude Successfully

The fourth Asia Summit on Global Health (ASGH) and the 15th Hong Kong International Medical and Healthcare Fair (Medical Fair) have conclud...

May 20, 2024 | News

Pfizer's Innovative Single-Dose Bivalent RSV Vaccine Approved in Hong Kong and Macau

The first and only bivalent, single-dose vaccine that fights against both RSV A and RSV B disease through two seasons has been approved by Hong K...

May 09, 2024 | News

Everest Medicines Secures NDA Approval for Nefecon® in Hong Kong, Expanding Treatment Reach in Asia

Everest Medicines announced that the Hong Kong Department of Health had approved Nefecon® for the treatment of primary immunoglobulin A nephropath...

May 02, 2024 | News

PolyU Partners with ZEISS Vision Care to Advance Global Myopia Control

The Hong Kong Polytechnic University (PolyU) is partnering with ZEISS Vision Care, one of the world's leading manufacturers of eyeglass lenses and ophthalm...

April 26, 2024 | News

Novel Molecules From Generative AI to Phase II: Pioneering TNIK Inhibitors for Fibrotic Diseases

In a groundbreaking study published in Nature Biotechnology, Insilico Medicine, along with its collaborators, showcases the journey of INS018_055 f...

March 13, 2024 | News

CAIR Launches Revolutionary CARES Copilot 1.0, Elevating AI in Healthcare

The Centre for Artificial Intelligence and Robotics (CAIR), under the Hong Kong Institute of Science & Innovation, Chinese Acad...

March 12, 2024 | News

Luye Pharma Launches Zepzelca® (Lurbinectedin) in Hong Kong, Macao

A symposium called the New Treatment Paradigm for Small Cell Lung Cancer (SCLC) organized by the Hong Kong Cancer Therapy Society (HKCTS) with support...

March 07, 2024 | News

HKUST Neuroscientists Unveil Groundbreaking Blood Test for Alzheimer's with Over 96% Accuracy

Neuroscientists from the Hong Kong University of Science and Technology (HKUST), led by Prof. Nancy IP, have introduced a highly accurate universal diagnos...

February 20, 2024 | News

Stay Connected